We are live on ! Find out more
GCM

Garland Capital Management Portfolio holdings

AUM $7.27M
1-Year Est. Return 14.85%
This Fund
S&P 500
This Quarter Est. Return
-2.21%
1 Year Est. Return
+14.85%
3 Year Est. Return
+55.71%
5 Year Est. Return
+87%
10 Year Est. Return
+180.2%
AUM
$147M
AUM Growth
-$6.19M
Cap. Flow
-$1.24M
Cap. Flow %
-0.84%
Top 10 Hldgs %
43.63%
Holding
35
New
1
Increased
2
Reduced
29
Closed

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$423K
2
CSCO icon
Cisco
CSCO
+$289K
3
MRK icon
Merck
MRK
+$277K
4
NVS icon
Novartis
NVS
+$265K
5
ROK icon
Rockwell Automation
ROK
+$263K

Sector Composition

Rank Sector Weight
1 Healthcare 28.64%
2 Financials 16.56%
3 Industrials 14.74%
4 Energy 9.68%
5 Technology 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTE icon
26
TotalEnergies
TTE
$191B
$3.63M 2.47%
61,437
-2,355
-4% -$145K
INTC icon
27
Intel
INTC
$487B
$3.51M 2.38%
107,289
-6,513
-6% -$185K
MDT icon
28
Medtronic
MDT
$115B
$3.47M 2.36%
+43,075
New +$3.51M
CCI icon
29
Crown Castle
CCI
$31.9B
$3.13M 2.13%
23,410
-870
-4% -$120K
DLR icon
30
Digital Realty Trust
DLR
$71.3B
$3.01M 2.05%
30,658
-1,607
-5% -$169K
VTV icon
31
Vanguard Morningstar Value ETF
VTV
$193B
$571K 0.39%
4,134
-300
-7% -$42.1K
VNQ icon
32
Vanguard Real Estate ETF
VNQ
$38.8B
$91.3K 0.06%
1,099
VBR icon
33
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.8B
$39.6K 0.03%
250
+2
+0.8% +$331
VOO icon
34
Vanguard S&P 500 ETF
VOO
$1.03T
$27.1K 0.02%
72
OGI
35
Organigram Holdings
OGI
$173M
$6.4K ﹤0.01%
2,500

Similar funds

Garland Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Garland Capital Management held 35 positions worth $147M, down 4% from $153M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 2.9%. Garland Capital Management opened 1 new position and made no exits, leaving the 35-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Industrials.

  • Garland Capital Management's largest Q1 2023 buy was Medtronic: 43,075 shares worth $3.47M.
  • Garland Capital Management added most to Johnson & Johnson in Q1 2023, an estimated $88.8K increase.
  • Garland Capital Management's biggest Q1 2023 reduction was AbbVie, cutting an estimated $423K.
  • Garland Capital Management's ten largest holdings make up 44% of its $147M portfolio in Q1 2023.
  • Garland Capital Management opened 1 new position and closed 0 in Q1 2023.
  • Garland Capital Management's portfolio value fell 4% quarter-over-quarter to $147M.

Based on Garland Capital Management's 13F filing for Q1 2023, filed 25 Apr 2023.